Keywords: Eisai, Zonegran, Russia, Approval, Halaven, Fycompa filing

Zonegran Russian approval prompts Eisai's expansion in that market

Article | 28 June 2012

Print This

Eisai (TYO: 4523), a leading Japanese drugmaker, says it plans to expand its operations into Russia, with the approval of its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in